As the principal component of the membrane skeleton, spectrin confers integrity and flexibility to red cell membranes. Although this network involves many interactions, the most common hemolytic anemia mutations that disrupt erythrocyte morphology affect the spectrin tetramerization domains. While much is known clinically about the resulting conditions (hereditary elliptocytosis and pyropoikilocytosis), the detailed structural basis for spectrin tetramerization and its disruption by hereditary anemia mutations remains elusive. Thus, to provide further insights into spectrin assembly and tetramer site mutations, a crystal structure of the spectrin tetramerization domain complex has been determined. Architecturally, this complex shows striking resemblance to multi-repeat spectrin fragments, with the interacting tetramer site region forming a central, composite repeat. This structure identifies conformational changes in α -spectrin that occur upon binding to β -spectrin and it reports the first structure of the β -spectrin tetramerization domain. Analysis of the interaction surfaces indicates an extensive interface dominated by hydrophobic contacts and supplemented by electrostatic complementarity. Analysis of evolutionarily conserved residues suggests additional surfaces that may form important interactions. Finally, mapping of hereditary anemia-related mutations onto the structure demonstrate that most, but not all, local hereditary anemia mutations map to the interacting domains. The potential molecular effects of these mutations are described.
Introduction
Preservation of red cell integrity and flexibility is conferred through an intracellular assembly of proteins known as the membrane skeleton. [1] [2] [3] Through specific interactions between integral membrane proteins, adaptor proteins, and spectrin, the membrane skeleton is effectively tethered to the cell membrane. Disorders that lead to deficiencies or defects in these membrane skeleton components often disrupt the properties of this stabilizing scaffold and consequently manifest themselves clinically in a common group of disorders known as hereditary elliptocytosis (HE), hereditary pyropoikilocytosis (HPP), and hereditary spherocytosis (HS). [3] [4] [5] [6] While clinical, biochemical, and genetic heterogeneity add to the complexity of these syndromes, the hallmark of these disorders is the presence of deformed and fragmented erythrocytes on peripheral blood smears. 3 From a molecular perspective, qualitative and quantitative disruptions of α -spectrin, β -spectrin, ankyrin, protein 4.1R, or glycophorin C, all have been linked to mechanical weakness or fragility of the erythrocyte membrane skeleton. However, it is the principal component of the red cell membrane skeleton, spectrin, to which the majority of the HE and HPP disorders have been attributed. 7 Spectrins (Figure 1a ) and other members of the spectrin superfamily are characterized by multiple, tandem, spectrin-type repeats. 8, 9 These homologous domains are each roughly 106 amino acids in length, adopt a three-helix bundle fold with a heptad repeat pattern of hydrophobic and hydrophilic residues, and are connected to adjacent repeats by ordered, α -helical linkers. In the case of the erythrocyte membrane skeleton, spectrin assembly begins with a lateral heterodimeric association of α and β subunits (Figure 1b, top) that is nucleated by specialized dimerization repeats located near the C-terminus of α -spectrin and the N-terminus of β -spectrin. [10] [11] [12] Subsequently, head-to-head interactions between two α /β dimers lead to the formation of a spectrin heterotetramer (Figure 1b, bottom) , the predominant form of the molecule in the erythroid membrane skeleton. Biochemical, biophysical, and clinical data implicated regions near the N-terminus of α -spectrin and C-terminus of β -spectrin as being responsible for tetramer formation. Furthermore, based on the length and continued heptad repeat in these regions, it had been hypothesized that these regions (α-spectrin partial repeat 0 and β -spectrin partial repeat 17) form a composite three-helix bundle that may bear similarity to complete spectrin repeats (Figure 1c ). [13] [14] [15] Given the necessity of spectrin tetramerization for the maintenance and stability of the red cell membrane, understanding the atomic basis for these intermolecular interactions can provide insight into the nature of HE and HPP. To address this, we have crystallized and determined an atomic structure of the complex of the human erythroid tetramerization domains consisting of α -spectrin repeats 0-1 and β -spectrin repeats 16-17 to 2.8 Å resolution. This is the first structure of a biologically-relevant, noncovalent complex between spectrin domains, and the first to depict the β -spectrin tetramerization domain.
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In addition to validating the long-standing hypothesis that the interaction between the tetramerization domains recapitulates a three-helix bundle, 16 the structural data indicate the relative positions of the partial domains with respect to one another and to their adjacent complete spectrin repeats. The overall orientation among the three repeats displays a striking resemblance to that of β IIspectrin repeats 14-16, thus validating that this complex truly does form a composite spectrin repeat. This likeness to complete spectrin repeats is further exemplified by the α -helical linkers that connect both partial repeats α 0 and β 17 to their adjacent domains. Overall, the structure is largely complete, although the first 18 amino acids of α -spectrin were disordered, as has been noted in other structures of this region, and thus were not observed. Other regions that showed disorder or variability in the structure included an interrupted helix in the C-terminal portion of β 17 and the A/B loop of repeat β
16. The interface of the complex is dominated by hydrophobic contacts with limited electrostatic interactions occurring among positively-charged residues of partial repeat α 0 and negatively-charged residues of partial repeat β 17. Mapping of conserved residues onto the molecular surface revealed that not only was the interaction interface conserved, but so too was one surface of the assembled complex hinting that this domain may be involved in other biologically relevant interactions. Finally, a mapping and analysis of known mutations that cause clinical disease underscores the importance of this interaction and presents probable explanations for the molecular basis of tetramerization defects.
Materials and Methods
Cloning, expression, and purification of spectrin fragments Constructs encompassing the tetramerization domains of human erythroid α -spectrin (repeats 0-1; residues 1-158) and human erythroid β -spectrin (repeats 16-17; residues 1902-2084) were individually cloned as GST-fusion proteins into the vector pGEX-2T. The expression and purification of the individual spectrin fragments has previously been described. 17 Purified α 0-1 and β 16-17 were mixed in a 1:1 molar ratio and incubated on ice overnight. The complex was then purified by gel filtration using S-100 resin (Sigma-Aldrich, St. Louis, MO) equilibrated with 10 mM Tris, 0.1 M NaCl, 1 mM EDTA, 1 mM DTT, pH 8.0 or on a Super G3000 SW XL column (Tosoh Corporation, Tokyo, Japan) equilibrated in 10 mM HEPES, 0.1 M NaCl, 1 mM TCEP, pH 7.4. Once purified, the complex was concentrated to 5-10 mg/mL and stored at 4 °C. Three cysteine mutants were constructed on the α 0-1 background (R60C, A99C, and A131C) using QuikChange ® site-directed mutagenesis (Agilent Technologies, La Jolla, CA) for use in mercury derivatization. Expression of selenomethionine-substituted proteins was performed using standard methods. 18 Purification of mutant and selenomethionine protein was identical to that of the wildtype.
Crystallization
Crystals of the α 0-1/β16-17 complex were grown by hanging-drop vapor diffusion on siliconized glass coverslips (Hampton Research, Aliso Viejo, CA). Two microliters of purified protein solution (5-10 mg/mL) were mixed with an equal volume of reservoir solution containing 0.1 M MES, pH 6.5, 10% PEG-6000, 10% glycerol, and 5 mM DTT and suspended over 0.75 mL of reservoir solution. Rectangular prismatic crystals (approximately 500 µm × 50 µm × 50 µm) grew at 4 °C within 12 h. Crystals were harvested and frozen in liquid nitrogen after serial transfer to 0.1 M MES, pH 6.5, 10% PEG-6000, 10% glycerol, 5 mM DTT, and 25% ethylene glycol in increasing steps of 5% ethylene glycol.
Data collection, crystal parameters, structure determination, and refinement Data were collected at 100 K using synchrotron radiation at the Advanced Photon Source (APS) LS-CAT beamline at Argonne National Laboratory, Argonne, IL. Initial data for this project were also collected at the X29 beamline at the National Synchrotron Light Source (NSLS) at Brookhaven National Laboratory, Upton, NY. Data were processed with XDS 19 and scaled with SCALA. 20 Additional processing was performed with programs from the CCP4 suite. 20 Data for the ethyl mercury phosphate (EMP) derivative crystals (presented in the Supplement) were processed in HKL2000. 21 For personal use only. Table I ). Crystals for the purpose of derivatization were grown in the absence of reducing agents; after the crystals formed, EMP was added to the crystallization drop at a final concentration of 5 mM for 16 h prior to harvesting.
Multiple Isomorphous Replacement Anomalous Scattering (MIRAS) phasing was carried out using the program autoSHARP, 22 which correctly located the labeled cysteines and selenomethionines in the asymmetric unit. The initial solvent-flattened map was of good quality, and the three-helix bundles of spectrin were recognized easily. An initial partial model was constructed using the low-resolution helix build module of ARP/wARP. 23 Subsequent manual model building and inspection were carried out using the program Coot. 24 Model refinement was performed using REFMAC5. 25 Even after refinement, not all regions of the molecules were visible, particularly in the N-terminal region of the α subunit. Proper placement of side chains was validated using the EMP-and selenomethionine-derivatized crystals that provided peaks in the anomalous difference map that were used as guides to register the sequence with both cysteines and methionines. TLS refinement was carried out by dividing the structure into three groups. The final model consists of residues: 19-158 for the α subunit (chain A), and 1900-1931 and 1934-2083 for the β subunit (chain B). The final model has an R factor and R free that converged at 26.8% and 29.9%, respectively, with an RMSD of 0.010 Å and 1.203° for bond lengths and bond angles, respectively, and with all residues within the favored regions of the Ramachandran plot. Statistics are listed in Table I and Supplemental Table I .
Figures
Figures of molecular models were made using PyMOL. 26 Calculation of electrostatic surfaces was performed with APBS. 27 Superpositions were done by lsqkab from the CCP4 software suite. 20 Conservation analysis was performed using the Consurf server. 28 
Data Deposition
Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with the accession number 3LBX.
Results

Protein purification, complex formation, and characterization
A structure of the complex between the tetramerization domains of human erythroid α -and β -spectrin was determined by X-ray crystallography. Selection and design of the component protein fragments were based on previous biochemical and biophysical studies that demonstrated human erythrocyte α 0-1 (residues 1-158) and β 16-17 (residues 1902-2084) were not only capable of forming a complex, but were each stable and homogenous in solution. 17 After purification of the individual protein fragments (described previously), the complex was reconstituted and purified by gel filtration. The complex was then characterized biophysically and used for crystallization. As expected, circular dichroism wavelength scans confirmed the large amount of α -helical secondary structure of the complex ( Figure S1 ), consistent with previous studies. 29, 30 Additionally, analytical ultracentrifugation to sedimentation equilibrium showed the complex to be heterodimeric in solution with a molecular weight corresponding to that of a 1:1 complex at 4 °C and a dissociation constant that is temperature dependent ( Figure S2 ). 
Each of these regions displays a canonical spectrin fold consisting of a triple-helical
For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From bundle with hydrophobic amino acids (positions a and d in the heptad repeat) facing the interior of the bundle, and hydrophilic side chains (positions e and g) being solvent-exposed. As has been observed with all other phased, multi-repeat spectrin structures to date, adjacent repeats are connected with α -helical linkers. [31] [32] [33] [34] [35] [36] [37] As predicted by structure-based homology modeling and biophysical measurements, the crystal structure confirms a complex dominated by α -helices. Finally, while the aforementioned studies contributed significantly in modeling the interactions present at the tetramerization interface, it is only with the structure of this complex that the precise nature of the molecular interactions can be discerned ( Figure 3 ).
The molecular model derived from the crystallographic data is largely complete. Although the Nterminal 18 amino acids of the α subunit were present and required for crystallization, this region was not observed in the density map indicating disorder. Various predictions, as well as biochemical experiments, showed that this region is not essential for tetramer formation, and its persistence as a disordered molecular fragment under crystallographic conditions is consistent with that observed in solution. 38 Furthermore, while the presence of disordered regions in spectrin structures is not unusual, 32 , 33 the molecular context of this portion of the molecule (i.e., being at the terminus of the molecule) likely lends itself to disorder. Other regions of the structure that exhibited significant flexibility or disorder included the A/B loop of repeat β
16 and the C-terminal tail of β 17. Near the C-terminus of repeat β 17, a single proline (Pro2071) residue imposes a kink that disrupts the helical fold. The most C-terminal residues (2072-2083) were observable, but significantly disordered, in the crystal structure. The density corresponding to this ending portion of the molecule had an overall helical character; however the side chains were poorly visible suggesting significant variability of the structure in this region ( Figure S3 ).
Comparison of the α 0-1/β16-17 complex with other three-repeat spectrin structures reveals a striking preservation of the overall spectrin fold in the composite repeat of α 0/β17 ( Figure 4 ). Additionally, the relative orientations of these repeats superimposed surprisingly well with the ankyrinbinding region fragment of human brain β -spectrin repeats 14-16 31 with an r.m.s.d. of 2.4 Å.
The interaction interface
Based on the long-standing hypothesis that the interaction surface between the partial repeats would mimic the interactions seen along the length of complete spectrin repeats, an interface rich in hydrophobic interactions was expected. Mapping of the intermolecular contacts observed in the structure (Figure 3 ; Figure S4 ) demonstrated that the binding surface is indeed dominated by hydrophobic contacts. In fact, relatively few electrostatic interactions were observed-Arg28 alpha with Glu2022 beta , Arg34 alpha with Glu2022 beta , and Glu2029 beta . Moreover, there was only one salt bridge (between Arg41 alpha and Glu2029 beta ) and only a few inter-chain hydrogen bonds (Gln29 alpha with Leu2068 beta , Arg45 alpha with Asp2036 beta , and Ser52 alpha with Phe2037 beta ). Interestingly, the crystal structure revealed a much larger number (53) of interactions than described previously by homology modeling (15) . 39 About half of the predicted 15 interactions were verified and the r.m.s.d. difference for main chain atoms between the models was 5.0 Å. While both models exhibited the same overall structure, even the relative positioning of the helices was different demonstrating both the utility and the limitations of homology modeling. The total buried surface area of each molecule was roughly 1050 Å 2 and spanned the length of the partial repeats. As mentioned, the N-terminal portion of α 0-1 was not observed in the crystal structure. Due to its proximity to the A/B loop of β
17, yet still being disordered, there is no evidence to suggest a stable interaction between the N-terminus of α -spectrin with the C-terminal β -spectrin repeats. It should be noted, that the protease-sensitive C-terminal tail of β -spectrin (residues 2085-2137) was not included due to its instability and could potentially interact with the N-terminal portion of the α chain. Nonetheless, experimental evidence to date indicates the fragments observed in the crystal structure are those primarily responsible for tetramer formation. 40 
Electrostatic surfaces
While the majority of the contacts between the two molecules are hydrophobic in nature, an analysis of the electrostatic surfaces (Figure 3c) indicates that the opposing faces of the interaction do show an overall complementarity of charge. Careful examination of the calculated electrostatic map, as well as the sequence of the interacting regions, shows an enrichment of acidic residues on the surface of the β chain (Glu2022, Glu2029, Glu2045, and Glu2055). Conversely, the central portion of the α chain is rich in basic residues (Arg28, Arg34, Arg41, Arg45, and Lys48). The majority of these charged residues do not form salt bridges and their electrostatic interactions in the structure are modest compared to the predominant hydrophobic interactions. However, the overall charges of these regions may serve to guide the two chains into place, with the structure of the tetramerization domain being "locked" through extensive hydrophobic interactions.
Discussion
Comparison to other structures of α -spectrin repeats 0-1 Recent structural work on α -spectrin repeats 0-1 has provided molecular models of both the erythroid and brain isoforms by NMR 38 and crystallography, respectively (Figure 4a ). 38 In both the NMR and prior crystallographic studies, the isolated α 0-1 domain exhibited a clear break in the helical character of the molecule. In the NMR structure (PDB ID: 1OWA), this break occurs coincident with the linker region connecting α 0 and α 1; that is, a helical region corresponding to α 0 is still present, but the two repeats seem to be folded independently. 38 The crystal structure of the corresponding human brain α -spectrin, on the other hand, maintains helical character for four additional helical turns before a secondary helical region (corresponding to the N-terminal half of brain spectrin α 0). While both structures agree well with the overall fold of repeat 1, the crystal structure of erythroid α
-spectrin in the complex shows a continuous helical linker between α 0 and α
1. This suggests that while regions of α 0 and its link to repeat 1 may be prone to fraying or multiple conformations in the unbound state, upon binding to the tetramerization domain of β -spectrin, these regions are stabilized. This conclusion also is supported by secondary structure prediction which shows a marked decrease in helical propensity precisely in the sequence (GQKLED) that is disordered in the NMR structure of α 0-1.
38, 41
In contrast to the variability in the linker region between repeats 0 and 1, the N-termini of the structures are almost uniformly disordered. Both the NMR structure of erythroid α -spectrin alone and the crystal structure of α -spectrin in complex with β -spectrin have a disordered tail of approximately 18 amino acids. 38 In the NMR structure, this is demonstrated by the N-terminal tail that neither has regular secondary structure nor converges to a single solution among the multiple models deposited. In the case of our crystal structure of α -spectrin in complex with β -spectrin, the N-terminal 18 amino acids are disordered and not observed in the electron density map. In the case of brain α -spectrin, only the first 8-10 residues are disordered; however in comparison to the erythroid isoform, the first 10 amino acids of brain α -spectrin are missing from the mature protein sequence. Taken together, this observation suggests that without additional interactions (which may or may not be present in vivo), the N-terminal portion of α -spectrin that precedes partial repeat 0 persists in an unstructured manner until the sequence AE(D/E)IQERR.
Comparison to other multi-repeat spectrin structures
The overall structure of the α 0-1/β16-17 complex displays a canonical spectrin fold consisting of triple-helical bundles connected with α -helical linkers. While this tertiary structure had been inferred from structure prediction, biophysical measurements, and structural studies, the precise structure and positioning of α 0-1 in relation to β 16-17 was unknown. With the data from the current study, comparisons to both "intact" and "composite" spectrin repeat structures can now be made.
Among published structures of spectrins, the majority are one-or two-repeat fragments. 32-38, 42, 43 To date, three, three-repeat structures have been determined: chicken brain α -spectrin repeats 15-17, human brain β -spectrin repeats 14-16, and human erythroid β -spectrin repeats 13-15 (in complex with a fragment of ankyrin). 31, 42, 44 While chicken brain α -spectrin repeats 15-17 are generally linear, both human brain β -spectrin repeats 14-16 and erythroid β -spectrin repeats 13-15 display a noticeable bend of ~50° between repeats 14 and 15. Surprisingly, the structure of β -spectrin repeats 14-16 superimposes quite well with the three repeats of the complex (Figure 4b ). This finding suggests that the complex formed by the tetramerization domains of
-spectrin does not simply complete a three-helix bundle-the lengths of the contributing helices, the location of the A/B loop of β -spectrin repeat 17, the presence of α -helical linkers, and the relative positioning of the three repeats indeed come together to form a very typical spectrin repeat.
Interestingly, the first structure of a single, spectrin-type repeat unit actually presented itself as a dimer under crystallization conditions ( Figure S5) . 37 In many ways, the interactions seen in that structure resemble the structure of the tetramerization domain as both structures form a composite spectrin bundle from two molecules that maintain the length and twist found in intact spectrins.
Conservation analysis
Sequence alignment and conservation mapping across species, tissue-specific isoforms, and alternative splicing variants using the Consurf server 28 onto the structure of both the α -and β -spectrin tetramerization domains (Figure 5a) indicate that, as expected, the interacting surface is more highly conserved than surfaces that do not participate in binding for these partial repeats. It should be noted that repeat β 17 is among the highest conserved across β -spectrins. 45 This analysis also indicates that the β -spectrin fragment maintains a higher degree of conservation than α , which supports the hypothesis that differences among α -spectrins are predominantly responsible for the varied affinities observed for different isoforms. 30 Interestingly, the same face of α 0 that is involved in binding β 17 maintains high conservation in repeat α 1 and β
(Figure 5b
). When assembled as a complex, part of the highly conserved surface is buried by the interaction. Nonetheless, an entire surface of highly conserved residues is presented on one face of the complex suggesting that it is a biologically important, conserved surface involved in additional interactions that are currently not defined.
Insights into the mechanism of tetramerization domain binding
Comparison of the various structures of α 0-1 suggests that in solution, partial repeat α 0 persists as an independent helix connected to repeat α 1 with a flexible linker. In contrast, the structure of α 0-1 in complex with β
16-17 displays a rigid, α
-helical linker connecting α 0 to α 1. As suggested by solution studies, 30 this change in conformation likely manifests itself as a stabilization and homogenization of the varied solution states of α 0-1. A more thorough analysis of the biophysical properties of the binding interaction can be extracted from both the structures discussed above and previous determination of the thermodynamic binding parameters. 17 First, based on earlier measurements of the thermodynamic binding parameters (ΔH = −33.1 ± 3.5 kcal/mole; −TΔS = 24.5 ± 3.4 kcal/mole; Δ G 23 °C = −8.6 kcal/mole; and K D = 400 ± 100 nM), 17 the entropy of the complex is decreased relative to that of the individual components. This suggests that the increase in entropy (mostly due to water being excluded by the formation of the hydrophobic interface of the complex) is not sufficient to fully overcome the entropic costs of orderly forming a stable complex and limiting the flexibility of the component subunits. The assessment that such reduced molecular flexibility occurs is supported by the observation of multiple conformations in the NMR structure of α 0-1. 38 Nonetheless, in concert with the endothermic, salt bridge, and hydrogen bondforming reactions, a sufficient favorable enthalpy is generated to allow formation of the complex.
Mapping of clinical mutations
The structure of the red cell spectrin α 0-1/β16-17 complex enables us to begin to address the physical basis for many clinically-relevant, disease-related mutations. A large number of point mutations that result in HE or HPP map to the partial repeats forming the tetramerization interface. 5 Additionally, mutations that truncate β -spectrin prematurely also can result in these disease states. The tetramer binding affinities for known HE/HPP mutations that map to the α 0 region have previously been analyzed. 17 The locations of these mutations in the tetramer interface are shown in Figure  6 and are color-coded based upon the previously observed decrease in tetramer binding affinity. As has been noted previously, the majority of HE/HPP mutations in this region eliminate or modify a positivelycharged residue (R28[C/H/L/S], R34W, R41W, R45[S/T], and K48R). All four R28 mutations extensively perturb binding affinity. Consistent with this, the interaction map ( Figure S4 ) shows this arginine participates in both hydrophobic and electrostatic interactions (with A2018 and E2022, respectively). This dual role for arginine has been observed in other spectrin structures where the aliphatic portion of an arginine side chain makes extensive hydrophobic contacts, while the charged, distal portion of the molecule is able to form hydrogen bonds, electrostatic interactions, or salt bridges. R41W shows a less dramatic, but nonetheless substantial, perturbation of binding (~20-fold weaker than wildtype), consistent with its electrostatic and hydrophobic interactions with β 17 residues. Surprisingly, R34W shows essentially wildtype binding affinity despite electrostatic interactions with glutamic acids and hydrophobic interactions on β
17. While such a change would require minor rearrangements of the packing of the side chains in the tetramerization interface, the added hydrophobic character of the tryptophan may compensate for the loss of electrostatic interactions. Additionally, hydrogen bond interactions with the indole NH may contribute to maintaining a favorable enthalpy for the binding reaction, as was measured by ITC. In addition, this side chain is partially exposed and it is very likely that the bulkier tryptophan protrudes from the surface of the complex. The remaining arginine mutations, R45S and R45T, exhibit substantial differences in binding affinity (K D > 200 and 14 µM, respectively). Based on the interactions observed in the structure, it is somewhat surprising that such a moderate structural change leads to a drastic effect on binding. However, given that R45 makes extensive hydrophobic contacts, it is possible that the larger and slightly more hydrophobic threonine is able to better maintain these contacts than serine. Biophysical measurements indicate that the R45T mutation leads to a less favorable change in enthalpy (likely due to the abolishment of the hydrogen bond interaction with D2036), while the entropy change is quite similar to that observed in the wildtype protein. Finally, the K48R mutation also exhibits wildtype binding, presumably because aliphatic portions of the lysine and arginine preserve normal hydrophobic interactions while the charged distal portion of the side chain is exposed on the surface of the complex. The frequent loss of a positive charge in HE/HPP mutations is quite interesting since the majority of contacts in the tetramer binding site are hydrophobic. This suggests the hypothesis that the lost charge affects long range electrostatically driven initial recognition, thereby adversely affecting k on . The reduced k on combined with perturbation of hydrophobic interactions that all of the arginine residues in question participate in, is likely to result in the drastic change in affinity observed for many of these mutations.
Other mutations in this portion of α -spectrin include I24(S/T), V31A, G46V, and L49F ( Figure  6b ). While no direct contacts were observed in the structure involving I24, this region of the structure is close to the disordered N-terminal tail of α -spectrin, making precise placement of the I24 side chain difficult at this resolution. Additionally, as this portion of the structure is in proximity to the C-terminal tail of β -spectrin, interactions of I24 with longer β -spectrin constructs may occur. The mutation of V31A, while structurally conservative, would eliminate some hydrophobic contacts and weaken the binding modestly, which is consistent with biophysical measurements indicating a more unfavorable change in entropy. Finally, both the G46V and L49F mutations likely cause local structural perturbations due to substitution with comparatively bulkier residues that affect the sterics of the binding interface. Consistent with the interactions evident in the structure of the complex, prior studies have proposed that these mutations affect the binding interface (G46V) 46 or α -spectrin itself (L49F).
47
The locations of β 17 mutations in the tetramer interface are shown in Figure 7 . These mutations can be grouped into two general categories: those that perturb the structural integrity of the β 17 domain and those that disrupt inter-chain contacts. In the structure, there is considerable contact between W2024 and W2061 (Figure 7a ). Changing the character of these closely-packed side chains is predicted to substantially perturb the tetramer interface, and therefore it is not surprising that W2024R, and W2061R dramatically disrupt tetramer binding, as previously reported by Nicolas et al. 48 A second group of mutations that are expected to severely perturb the local structure of β 17 include S2019P, A2053P, and R2064P (Figure 7b ). These three residues do not directly interact with α -spectrin; however, their proximity to residues that interact is expected to make mutation of these residues in helical regions to proline highly detrimental. Finally, a number of premature truncations of β -spectrin occur in the β 17 B helix. Most of these would disrupt a significant portion of the binding interface. The only clinical nonsense mutation in this region (the remainder of the characterized truncations are due to frame shift mutations), E2069X, is near the end of the B helix, but it would remove a number of residues (2074, 2075, and 2078) that directly interact with the α 0 domain. Finally, several of the remaining mutations are expected to disrupt specific β 17-α0 interactions including A2018G, A2018D, and L2025R (Figure 7c ). In the presented structure, these residues form direct hydrophobic contacts with α -spectrin, and therefore all three mutations are expected to disrupt this interaction either by eliminating hydrophobic interactions, as in A2018G, or substituting a comparatively bulky, charged residue, as in A2018D and L2025R. It is less apparent that A2023V would disrupt either the β 17 structure or its interaction with α 0 as it is on the outside of the bundle, which is consistent with the previous findings that showed the binding affinity for this mutant was nearly that observed for the wildtype protein. 48 In conclusion, this crystal structure of the spectrin tetramerization domain complex now provides novel insights into this critical, dynamic red cell membrane skeleton assembly site. The structure illustrates the atomic features that allow this interaction to occur and provides evidence for conformational changes in α -spectrin in response to tetramer formation. The structure of this assembly shows a striking resemblance to intact spectrin tri-repeats and also provides the first structure of the tetramerization domain of β -spectrin. A detailed analysis of the molecular surfaces affords novel insights into the nature of many HE/HPP-related mutations, while conservation analysis suggests additional surfaces that may form additional important interactions. This work reveals some of the key features important for spectrin tetramer formation and provides a guide for designing further experiments to explore more of the details of spectrin assembly.
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